Stryker Corp
SYKNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 19/3020% below fair value
$306.81+14.95 (+5.12%)
Close on Nov 2, 2026Market cap $117.68BP/E 32.7Yield –
Stryker Knees by Quarter
Knees (Triathlon Primary/Revision & Mako Robotic Knee Implants) — U.S. Sales Growth YoY (Reported / Constant Currency, %) (%)
Stryker Knees: 1.3% in Q3 2026, down 7.1 pts from a year earlier.
Latest, Q3 2026
1.3%
Period ended Sep 30, 2026
Change on a year earlier
-7.1 pts
8.4% in Q3 2025
History
40 quarters
Since Q4 2015
Sources
40
Documents cited below
Where the Q3 2026 figure comes from
Reported in Stryker Form 8-K Supplemental Sales Schedules (100% USD; Reported = Constant Currency).
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Cite this data
StockData. (2026). Stryker Knees (%), quarterly Q4 2015–Q3 2026 [Data set]. Compiled from Stryker SEC filings and investor materials. https://stockdatahq.com/stocks/syk/kpis/fran-knees-us-rep
See every metric in the Stryker KPI table. Data updated Nov 2, 2026.